Bio-Rad Laboratories (BIO) Return on Equity (2016 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Return on Equity for 16 consecutive years, with 0.11% as the latest value for Q4 2025.
- Quarterly Return on Equity rose 37.0% to 0.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.11% through Dec 2025, up 37.0% year-over-year, with the annual reading at 0.11% for FY2025, 35.0% up from the prior year.
- Return on Equity for Q4 2025 was 0.11% at Bio-Rad Laboratories, up from 0.1% in the prior quarter.
- The five-year high for Return on Equity was 0.5% in Q3 2021, with the low at 0.69% in Q3 2022.
- Average Return on Equity over 5 years is 0.04%, with a median of 0.04% recorded in 2023.
- The sharpest move saw Return on Equity plummeted -119bps in 2022, then surged 67bps in 2023.
- Over 5 years, Return on Equity stood at 0.29% in 2021, then plummeted by -237bps to 0.4% in 2022, then skyrocketed by 81bps to 0.07% in 2023, then plummeted by -253bps to 0.26% in 2024, then soared by 141bps to 0.11% in 2025.
- According to Business Quant data, Return on Equity over the past three periods came in at 0.11%, 0.1%, and 0.05% for Q4 2025, Q3 2025, and Q2 2025 respectively.